SEC Comment Letter for ORAGENICS INC (OGEN) (CIK 0001174940) (OGEN) — May 4, 2018
ORAGENICS INC (OGEN) (CIK 0001174940)
Date: May 4, 2018 · CIK: 0001174940 · Accession: 0000000000-18-013933
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-224498
Letter
May 4, 2018 Michael Sullivan Chief Financial Officer Oragenics, Inc. 4902 Eisenhower Boulevard, Suite 125 Tampa, FL 33634 Re:Oragenics, Inc. Registration Statement on Form S-1 Filed April 27, 2018 File No. 333-224498 Dear Mr. Sullivan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Christine Westbrook at (202) 551-5019 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Mark A. Catchur, Esq.
Show Raw Text
May 4, 2018
Michael Sullivan
Chief Financial Officer
Oragenics, Inc.
4902 Eisenhower Boulevard, Suite 125
Tampa, FL 33634
Re:Oragenics, Inc.
Registration Statement on Form S-1
Filed April 27, 2018
File No. 333-224498
Dear Mr. Sullivan:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Christine Westbrook at (202) 551-5019 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Mark A. Catchur, Esq.